Literature DB >> 17267636

Type IV neonatal early-onset group B streptococcal disease in a United States hospital.

Karen M Puopolo1, Lawrence C Madoff.   

Abstract

Group B streptococcus (GBS) serotypes causing neonatal disease vary by geographic region. Surveillance at the Brigham and Women's Hospital in Boston, Massachusetts, revealed a case of neonatal early-onset sepsis caused by type IV GBS. Neonatal type IV disease occurs in the Middle East but has not recently been described in U.S. infants.

Entities:  

Mesh：

Year:  2007        PMID： 17267636      PMCID： PMC1865845          DOI： 10.1128/JCM.02487-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

1.  Group B streptococcal serotype distribution of isolates from colonized pregnant women at the time of delivery in United Arab Emirates.

Authors:  A Amin; Y M Abdulrazzaq; S Uduman
Journal:  J Infect       Date:  2002-07       Impact factor: 6.072

2.  The carriage of group B streptococci in Turkish pregnant women and its transmission rate in newborns and serotype distribution.

Authors:  Aynur Eren; Metin Küçükercan; Naz Oğuzoğlu; Nuriye Unal; Ateş Karateke
Journal:  Turk J Pediatr       Date:  2005 Jan-Mar       Impact factor: 0.552

3.  Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups.

Authors:  D F Zaleznik; M A Rench; S Hillier; M A Krohn; R Platt; M L Lee; A E Flores; P Ferrieri; C J Baker
Journal:  Clin Infect Dis       Date:  2000-02       Impact factor: 9.079

4.  Serotype identification of group B streptococci by PCR and sequencing.

Authors:  Fanrong Kong; Sonia Gowan; Diana Martin; Gregory James; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

5.  Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001.

Authors:  E Persson; S Berg; B Trollfors; P Larsson; E Ek; E Backhaus; B E B Claesson; L Jonsson; G Rådberg; T Ripa; S Johansson
Journal:  Clin Microbiol Infect       Date:  2004-09       Impact factor: 8.067

6.  Cell wall proteins of group B Streptococcus and low incidence of neonatal disease in southern Israel.

Authors:  Dror Marchaim; Mordechai Hallak; Limor Gortzak-Uzan; Nechama Peled; Klaris Riesenberg; Francisc Schlaeffer
Journal:  J Reprod Med       Date:  2003-09       Impact factor: 0.142

Review 7.  Recurrent group B streptococcal infections in infants: clinical and microbiologic aspects.

Authors:  P A Green; K V Singh; B E Murray; C J Baker
Journal:  J Pediatr       Date:  1994-12       Impact factor: 4.406

8.  Invasive group B streptococcal disease: the emergence of serotype V.

Authors:  H M Blumberg; D S Stephens; M Modansky; M Erwin; J Elliot; R R Facklam; A Schuchat; W Baughman; M M Farley
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

Review 9.  Glycoconjugate vaccines to prevent group B streptococcal infections.

Authors:  Lawrence C Paoletti; Dennis L Kasper
Journal:  Expert Opin Biol Ther       Date:  2003-09       Impact factor: 4.388

10.  Diversity of surface protein expression in group B streptococcal colonizing & invasive isolates.

Authors:  P Ferrieri; C J Baker; S L Hillier; A E Flores
Journal:  Indian J Med Res       Date:  2004-05       Impact factor: 2.375
View more
  7 in total

1.  Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States.

Authors:  Michelle J Diedrick; Aurea E Flores; Sharon L Hillier; Roberta Creti; Patricia Ferrieri
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

2.  High Incidence of Macrolide and Tetracycline Resistance among Streptococcus Agalactiae Strains Isolated from Clinical Samples in Tehran, Iran.

Authors:  Mohammad Emaneini; Akbar Mirsalehian; Reza Beigvierdi; Abbas Ali Imani Fooladi; Fatemeh Asadi; Fereshteh Jabalameli; Morovat Taherikalani
Journal:  Maedica (Buchar)       Date:  2014-06

3.  Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.

Authors:  Hsiao-Hui Yang; Samantha J Mascuch; Lawrence C Madoff; Lawrence C Paoletti
Journal:  Clin Vaccine Immunol       Date:  2008-05-07

4.  Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness.

Authors:  E R Martins; M A Pessanha; M Ramirez; J Melo-Cristino
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

5.  Group B streptococcus serotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distribution.

Authors:  Danielle L Ippolito; Wesley A James; Deborah Tinnemore; Raywin R Huang; Mary J Dehart; Julie Williams; Mark A Wingerd; Samandra T Demons
Journal:  BMC Infect Dis       Date:  2010-11-24       Impact factor: 3.090

Review 6.  A Vaccine Against Group B Streptococcus: Recent Advances.

Authors:  Clara Carreras-Abad; Laxmee Ramkhelawon; Paul T Heath; Kirsty Le Doare
Journal:  Infect Drug Resist       Date:  2020-04-29       Impact factor: 4.003

7.  Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000-2010.

Authors:  Patricia Ferrieri; Ruth Lynfield; Roberta Creti; Aurea E Flores
Journal:  Emerg Infect Dis       Date:  2013-04       Impact factor: 6.883
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.